Related Experiment Video

Updated: Apr 23, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

917

Pathways and barriers to developing pediatric research consortia

Erich Sorantin1

  • 1Division of Pediatric Radiology, Department of Radiology, Medical University Graz, Auenbruggerplatz 34, A-8,036, Graz, Austria, erich.sorantin@medunigraz.at.

Pediatric Radiology
|September 24, 2014
PubMed

Insights

Pediatric radiology involves imaging diverse age and weight ranges, presenting unique challenges due to child maturation. International research collaborations are crucial for knowledge exchange and overcoming these complex hurdles in pediatric imaging.

Area of Science:

  • Pediatric Radiology
  • Medical Imaging
  • Research Collaboration

Background:

  • Pediatric radiology encompasses imaging patients from premature infants to 19-year-olds, with significant variations in weight and physiology.
  • Children are not merely small adults; their unique developmental stages (maturation) present a complex, four-dimensional imaging challenge.
  • Effective knowledge transfer and teamwork are essential for addressing the multidimensional complexities in pediatric imaging.

Purpose of the Study:

  • To explore the pathways and barriers involved in establishing and managing international, inter-institutional academic networks in pediatric radiology.
  • To provide insights based on the author's experience in developing and running collaborative research networks.

Main Methods:

  • The article draws upon the author's practical experience in initiating and operating international academic networks.
  • Analysis of cooperation pathways and barriers within research consortia.

Main Results:

  • Research consortia are identified as a valuable approach for fostering experience exchange and knowledge transfer in pediatric radiology.
  • Barriers to cooperation are categorized into external (institutional), internal (departmental), organizational, and individual researcher factors.

Conclusions:

  • International, inter-institutional collaborations are vital for advancing pediatric radiology research.
  • Understanding and addressing the identified barriers are key to successful research network development and operation.

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

14.4K
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

8.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
543
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
941
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.7K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
93.4K